Cholinergic Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Dementia with Lewy bodies (DLB) is characterized by progressive cognitive decline, visual hallucinations, parkinsonism, and prominent cholinergic deficiency. Cholinergic neuron loss is a major contributor to the cognitive symptoms and is more severe than in Alzheimer's disease. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Medium |
| Region | Lewy Body Type | Clinical Correlation |
|---|---|---|
| Cortex | Cortical LB | Visual hallucinations |
| Limbic | Transitional LB | Mood symptoms |
| Substantia nigra | Brainstem LB | Parkinsonism |
The study of Cholinergic Neurons In Dementia With Lewy Bodies has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ballard C, et al. Cholinergic dysfunction in DLB. 2021. ↩︎